Your browser doesn't support javascript.
loading
Hormone receptor status of breast cancer in India: a study of 798 tumours.
Desai, S B; Moonim, M T; Gill, A K; Punia, R S; Naresh, K N; Chinoy, R F.
Affiliation
  • Desai SB; Department of Pathology, Tata Memorial Hospital, Mumbai-400 012, India.
Breast ; 9(5): 267-70; discussion 270, 2000 Oct.
Article in En | MEDLINE | ID: mdl-14732176
ABSTRACT
The objectives of this study were to document the oestrogen and progesterone receptor (ER & PR) status of breast cancer in the Indian population (as done by immunohistochemistry on paraffin blocks), and correlate the steroid receptor status of breast cancer with all relevant patient and tumour characteristics. Our current data have been compared with previously published data from other centres. In contrast to the higher rates reported in the Western literature, only 32.6% of our tumours were ER positive and 46.1% were PR positive. Tumours were separated into four categories ER+PR+ (25%), ER+PR- (7.4%), ER-PR+ (21.1%) and ER-PR- (46.5%). ER and PR immunoreactivity increased with advancing age, and correlated with the presence of elastosis. Infiltrating lobular carcinoma, mucinous carcinoma, and mixed tumours were more frequently ER & PR positive. High-grade infiltrating duct carcinomas, pure comedo ductal carcinoma in situ, and medullary carcinoma were predominantly ER & PR negative. The presence of necrosis and lymphovascular invasion showed an inverse relationship with ER and PR reactivity.
Search on Google
Collection: 01-internacional Database: MEDLINE Language: En Journal: Breast Journal subject: ENDOCRINOLOGIA / NEOPLASIAS Year: 2000 Document type: Article Affiliation country: India
Search on Google
Collection: 01-internacional Database: MEDLINE Language: En Journal: Breast Journal subject: ENDOCRINOLOGIA / NEOPLASIAS Year: 2000 Document type: Article Affiliation country: India